Related Experiment Video
Updated: Jun 8, 2026
08:15
Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
Antidepressants: clinically relevant drug interactions to be considered
Rene Schellander1, Josef Donnerer
1Institute of Experimental and Clinical Pharmacology, Medical University of Graz, Graz, Austria.
Pharmacology
|September 11, 2010
Summary
Antidepressant drugs (ADs) can cause harmful interactions due to their effects on cytochrome P450 (CYP) enzymes. While newer ADs are safer, awareness of potential drug interactions is crucial for patient safety.
Area of Science:
- Pharmacology
- Clinical Pharmacy
- Drug Interactions
Background:
- Drug interactions are a significant clinical challenge, particularly with frequently prescribed antidepressant drugs (ADs).
- ADs, including selective serotonin reuptake inhibitors (SSRIs), can interact due to their mechanisms of action and influence on cytochrome P450 (CYP) enzymes.
- Despite improved safety profiles of newer ADs, their interaction potential necessitates careful consideration.
Purpose of the Study:
- To review current literature on clinically relevant drug interactions involving antidepressants.
- To highlight key pharmacodynamic interactions and the impact of ADs on CYP enzymes.
- To inform prescription recommendations, especially for elderly patients and those with polypharmacy.
Main Methods:
- Literature review of current scientific publications on antidepressant drug interactions.
- Selection of clinically relevant interaction examples.
- Analysis of pharmacodynamic interactions and CYP enzyme effects.
Main Results:
- Pharmacodynamic interactions discussed include serotonin syndrome, increased bleeding risk with SSRIs, and Q-T interval prolongation.
- New-generation ADs exhibit variable inhibitory effects on CYP enzymes, impacting polypharmacy and elderly patient prescriptions.
- St. John's wort can induce CYP enzymes, potentially lowering plasma levels of other drugs.
Conclusions:
- A notable safety gap exists between potential and observed drug-drug interactions with ADs.
- Understanding ADs' interaction profiles is vital for safe prescribing practices.
- Further research and clinical vigilance are necessary to manage antidepressant-related drug interactions effectively.
Related Concept Videos
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:25Pharmacokinetics: Drug–Drug Interactions
Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications